Stryker’s Biotech Division Receives FDA Warning Letter
KALAMAZOO - Stryker Corporation said Tuesday that its Biotech division has received a warning letter from the U. S. Food and Drug Administration related to quality systems and compliance issues at its Hopkinton, Massachusetts location. The warning letter concerns observations made during an inspection that was initiated in September 2007. The letter primarily cites issues